Arthur S. Przybyl

2014

In 2014, Arthur S. Przybyl earned a total compensation of $1.8M as President, Chief Executive Officer and Director at ANI Pharmaceuticals, a 67% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$447,300
Option Awards$454,155
Salary$461,452
Stock Awards$379,008
Other$10,000
Total$1,751,915

Przybyl received $461.5K in salary, accounting for 26% of the total pay in 2014.

Przybyl also received $447.3K in non-equity incentive plan, $454.2K in option awards, $379K in stock awards and $10K in other compensation.

Rankings

In 2014, Arthur S. Przybyl's compensation ranked 5,074th out of 13,032 executives tracked by ExecPay. In other words, Przybyl earned more than 61.1% of executives.

ClassificationRankingPercentile
All
5,074
out of 13,032
61st
Division
Manufacturing
1,809
out of 4,966
64th
Major group
Chemicals And Allied Products
600
out of 1,686
64th
Industry group
Drugs
458
out of 1,365
66th
Industry
Pharmaceutical Preparations
366
out of 1,043
65th
Source: SEC filing on April 6, 2017.

Przybyl's colleagues

We found three more compensation records of executives who worked with Arthur S. Przybyl at ANI Pharmaceuticals in 2014.

2014

Robert Schrepfer

ANI Pharmaceuticals

Senior Vice President, New Business Development and Specialty Sales

2014

Charlotte Arnold

ANI Pharmaceuticals

Chief Financial Officer

2014

James Marken

ANI Pharmaceuticals

Senior Vice President, Operations and Product Development

News

You may also like